Optimizing the management of advanced breast cancer in the Asia-Pacific region: Role of clinical trials and treatment guidelines

Shin Cheh Chen*, Alex Yuang Chi Chang

*Corresponding author for this work

Research output: Contribution to journalJournal Article peer-review

Abstract

There is an urgent need to identify the best ways to manage breast cancer in women in the Asia-Pacific region. It is increasingly recognized that disease patterns, efficacy and toxicities of various treatment regimens, differ between Asia-Pacific women and women in the West. Despite these differences, breast cancer treatment in the Asia-Pacific region often follows evidence-based treatment guidelines based on Western clinical trials. To obtain the best possible outcomes in the Asia-Pacific region, country-specific breast cancer clinical trials and registries are crucial. Findings should be integrated into country-specific consensus treatment guidelines. These measures would facilitate the best choice of drugs, the optimal doses, and the optimal schedules for treating women with breast cancer in the Asia-Pacific region.

Original languageEnglish
Pages (from-to)S24-S29
JournalAsia-Pacific Journal of Clinical Oncology
Volume4
Issue numberSUPPL. 3
DOIs
StatePublished - 2008
Externally publishedYes

Keywords

  • Asia-Pacific
  • Breast cancer
  • Clinical trials
  • Treatment guidelines

Fingerprint

Dive into the research topics of 'Optimizing the management of advanced breast cancer in the Asia-Pacific region: Role of clinical trials and treatment guidelines'. Together they form a unique fingerprint.

Cite this